AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 232 min read$ENVA

TEBBE MARK sold $4.0M of ENVA

TEBBE MARK sold 20,000 shares of Enova International, Inc. (ENVA) at $201.37 ($4.03M total) on 2026-06-18.

Original reporting
SEC EDGAR · TEBBE MARK
Published Jun 23, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This is a primary-source disclosure of an insider sale. It can modestly influence short-term sentiment, but it does not introduce new operational, financial, or regulatory information about ENVA.

02

Market read

Traders may monitor whether this sale is part of a broader pattern, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Form 4 sales often have non-informational drivers; without additional context (e.g., repeated sales, size vs. typical activity, or concurrent operational news), the trading signal is weak.

Relevance 6/10Novelty 3/10Timing: after-hours/filing timestamp (2026-06-23) for the 2026-06-18 sale disclosure

Background

SEC Form 4 insider transaction for Enova International, Inc. (ENVA): director TEBBE MARK sold 20,000 shares at $201.3680 on 2026-06-18; filing made 2026-06-23.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova director TEBBE MARK filed a Form 4 selling 20,000 shares at $201.3680 on 2026-06-18, totaling ~$4.03M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by other news.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it provides no new company fundamentals, guidance, or transaction terms beyond the trade size and price.

Market effects

Sector

No clear sector read-through; this is an individual insider transaction without stated company-wide developments.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be planned liquidity (even though the filing notes no pre-arranged 10b5-1 plan), personal diversification, or tax-related selling rather than a bearish signal.

Key entities

  • issuer
    Enova International, Inc.

    Company whose director filed the Form 4 insider sale.

  • insider
    TEBBE MARK

    Director who sold 20,000 shares in an open-market transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ENVA insider trading history →

Related articles

OCT 23
$ENVAMed

Citizens raises Enova stock price target on strong growth outlook

Citizens raised its price target for Enova International (NYSE:ENVA) to $220 from $215, citing strong growth and stable credit quality. The company reported 30%+ originations growth and 30%+ EPS growth for multiple quarters. Enova's stock has gained 55% over the past year, but may be overvalued according to InvestingPro's Fair Value analysis. Citizens also increased its 2027 adjusted EPS estimate to $22.03 from $21.47, expecting more aggressive share buybacks.

investing.com2 min
OCT 23
$ENVAMedAI 8/10

Enova International Inc (ENVA) Q3 2026 Earnings Call Highlights: Revenue Tops $1 Billion

Enova International Inc (ENVA) reported Q3 2026 revenue exceeding $1 billion, up 26% YoY, with adjusted EPS increasing 33% to $4.48. Originations grew 31% YoY to $2.6 billion, marking 12 consecutive quarters of at least 20% growth. The company noted increased marketing expenses and SMB delinquencies, while withdrawing bank applications. Management expects Q4 2026 revenue to rise 25% YoY with stable margins.

finance.yahoo.com3 min
OCT 23
$ENVAMedAI 8/10

Enova Tops $1 Billion Quarterly Revenue as Online Lending

Enova reported Q3 2026 revenue of $1.1 billion, up 26% YoY, with originations and adjusted EPS also rising significantly. Net charge-off ratio improved to 8.1%. The company's portfolio reached $5.9 billion, with small business products comprising 68%. Enova withdrew its bank regulatory applications for Grasshopper Bancorp acquisition, citing regulatory misalignment, but expects continued growth.

pymnts.com2 min
OCT 22
$ENVAMed

What Enova International (ENVA) Said on Its Q3 Earnings Call

Enova International (ENVA) reported Q3 improvements in net charge-off ratios and revenue margins, with consolidated net revenue margin at 61%. The company expects Q4 margins between 55% and 60%. Marketing expenses rose to 23% of revenue, supporting growth. Enova has $1.3B in liquidity and repurchased 243,000 shares. It forecasts 25% revenue growth and 30-35% adjusted EPS increase for Q4. The company is exploring new product opportunities in consumer and small-business lending.

finance.yahoo.com3 min
OCT 22
$ENVAMedAI 8/10

Enova (ENVA) Q3 2026 Earnings Call Transcript

Enova (ENVA) reported Q3 2026 earnings with 26% revenue growth to over $1 billion, driven by 30% portfolio growth. Consumer and small business originations increased 37% and 28% respectively. Adjusted EPS rose 33%. Net charge-off rates improved, with the consolidated rate at 8.1%. The company expects strong Q4 results, citing resilient macroeconomic conditions and consumer spending.

finance.yahoo.com3 min